315 related articles for article (PubMed ID: 20880402)
21. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
[TBL] [Abstract][Full Text] [Related]
24. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
Covic L; Gresser AL; Kuliopulos A
Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory Effects of P2Y12 Receptor Antagonist on PAR1- and PAR4-AP-Induced Platelet Aggregation in Patients with Stroke or TIA.
Kamada A; Shimizu M; Oura K; Yoshida M; Tsuda K; Oi K; Ishigaku Y; Natori T; Narumi S; Itabashi R; Maeda T; Terayama Y
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105547. PubMed ID: 33360254
[TBL] [Abstract][Full Text] [Related]
26. Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide.
Kirkby NS; Lundberg MH; Chan MV; Vojnovic I; Solomon AB; Emerson M; Mitchell JA; Warner TD
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15782-7. PubMed ID: 24003163
[TBL] [Abstract][Full Text] [Related]
27. The catalytic subunit of protein phosphatase 1 gamma regulates thrombin-induced murine platelet alpha(IIb)beta(3) function.
Gushiken FC; Hyojeong H; Pradhan S; Langlois KW; Alrehani N; Cruz MA; Rumbaut RE; Vijayan KV
PLoS One; 2009 Dec; 4(12):e8304. PubMed ID: 20016849
[TBL] [Abstract][Full Text] [Related]
28. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization.
Mazharian A; Roger S; Berrou E; Adam F; Kauskot A; Nurden P; Jandrot-Perrus M; Bryckaert M
J Biol Chem; 2007 Feb; 282(8):5478-87. PubMed ID: 17200114
[TBL] [Abstract][Full Text] [Related]
29. Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin.
Adam F; Guillin MC; Jandrot-Perrus M
Eur J Biochem; 2003 Jul; 270(14):2959-70. PubMed ID: 12846829
[TBL] [Abstract][Full Text] [Related]
30. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
31. PAR4-Mediated PI3K/Akt and RhoA/ROCK Signaling Pathways Are Essential for Thrombin-Induced Morphological Changes in MEG-01 Cells.
Heo Y; Jeon H; Namkung W
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054966
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway.
Dong J; Lin J; Wang B; He S; Wu C; Kushwaha KK; Mohabeer N; Su Y; Fang H; Huang K; Li D
Cell Physiol Biochem; 2015; 35(1):160-74. PubMed ID: 25591759
[TBL] [Abstract][Full Text] [Related]
33. Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets.
Wu CC; Wang WY; Wei CK; Teng CM
Thromb Haemost; 2011 Jan; 105(1):88-95. PubMed ID: 21057701
[TBL] [Abstract][Full Text] [Related]
34. [Effect of protein kinase C and calcium on the thrombin receptors activation].
Han Y; Wang ZY; Xie Y; Zhang W; Dai L; Shen WH; Wu DP; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):154-7. PubMed ID: 18788611
[TBL] [Abstract][Full Text] [Related]
35. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.
Fälker K; Haglund L; Gunnarsson P; Nylander M; Lindahl TL; Grenegård M
Biochem J; 2011 Jun; 436(2):469-80. PubMed ID: 21391917
[TBL] [Abstract][Full Text] [Related]
36. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
37. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
38. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets.
Cifuni SM; Wagner DD; Bergmeier W
Blood; 2008 Sep; 112(5):1696-703. PubMed ID: 18544684
[TBL] [Abstract][Full Text] [Related]
39. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.
Carrim N; Arthur JF; Hamilton JR; Gardiner EE; Andrews RK; Moran N; Berndt MC; Metharom P
Redox Biol; 2015 Dec; 6():640-647. PubMed ID: 26569550
[TBL] [Abstract][Full Text] [Related]
40. PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis.
Voss B; McLaughlin JN; Holinstat M; Zent R; Hamm HE
Mol Pharmacol; 2007 May; 71(5):1399-406. PubMed ID: 17303701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]